Absci ABSI
NASDAQ ABSI
$10.77 +0.63 (+6.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

Absci (ABSI) Capital Expenditures (2020 - 2026)

Updated

Absci's Capital Expenditures was $1,000 in Q2 2026, down 99.6% from $223,000 a year earlier and down 96.7% from the prior quarter.

Analysis

Absci (ABSI) Capital Expenditures (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Absci's Capital Expenditures was $890,000 through Jun 30, 2026, up 179.0% year-over-year; for FY2025, it came in at $1.11 million, up 174.0% from FY2024.

  • Capital Expenditures shows a five-year compound annual growth rate of -12.7% (FY2020 to FY2025).
  • In earlier years, Capital Expenditures was $404,000 in FY2024 (-53.0%), $860,000 in FY2023 (-94.7%), $16.18 million in FY2022 (-57.5%) and $38.05 million in FY2021.
  • Quarterly Capital Expenditures has moved between -$103,000 (Q4 2025) and $8.32 million (Q4 2021) over five years.
  • Compared with a year earlier, Capital Expenditures was higher in two of the last five quarters, with an average decline of 32.3%.
  • The best year-over-year quarter for Capital Expenditures over five years was Q4 2021 (growth of 803.9%); the worst was Q2 2026 (a decline of 99.6%).
  • Per Business Quant data, ABSI's Capital Expenditures in the three quarters before Q2 2026 was $30,000 (Q1 2026), -$103,000 (Q4 2025) and $962,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Absci 1.74 Bn 1.12 Bn - 1,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,000.00
Mar 31, 2026 30,000.00
Dec 31, 2025 -103,000.00
Sep 30, 2025 962,000.00
Jun 30, 2025 223,000.00
Mar 31, 2025 25,000.00
Dec 31, 2024 23,000.00
Sep 30, 2024 48,000.00
Jun 30, 2024 333,000.00
Dec 31, 2023 17,000.00
Sep 30, 2023 307,000.00
Jun 30, 2023 256,000.00
Mar 31, 2023 280,000.00
Dec 31, 2022 560,000.00
Sep 30, 2022 4.87 Mn
Jun 30, 2022 3.89 Mn
Mar 31, 2022 6.86 Mn
Dec 31, 2021 8.32 Mn
Sep 30, 2021 5.62 Mn
Jun 30, 2021 17.75 Mn
API Access

Absci Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ABSI&period=max&api_key=YOUR_API_KEY